Occudo Quantitative Strategies LP Revance Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$5.81 - $11.2 $263,332 - $507,628
45,324 New
45,324 $398,000
Q1 2023

May 15, 2023
SELL
$18.36 - $35.27 $345,792 - $664,275
-18,834 Reduced 46.22%
21,918 $705,000
Q4 2022

Feb 14, 2023
BUY
$18.32 - $30.66 $444,772 - $744,363
24,278 Added 147.37%
40,752 $752,000
Q3 2022

Nov 14, 2022
SELL
$14.33 - $28.47 $391,137 - $777,088
-27,295 Reduced 62.36%
16,474 $445,000
Q2 2022

Aug 15, 2022
BUY
$11.52 - $20.4 $504,218 - $892,887
43,769 New
43,769 $605,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email